Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies.
Ga Young AhnChang-Hee SuhYong-Gil KimYong-Beom ParkSeung Cheol ShimSang-Heon LeeShin-Seok LeeSang-Cheol BaeDae Hyun YooPublished in: Journal of Korean medical science (2020)
RTX could be an effective and relatively safe therapeutic option in patients with refractory IIM.